Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-22-025171

COO, CFO acquired 4,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Kung Winston COO, CFO 2022-04-20 Option exercise +4,000 $3.22 $12,880 10,600 D
Derivatives
Kung Winston COO, CFO 2022-04-20 Option exercise · Stock Option (right to buy) −4,000 210,034 D
Loading xslF345X03/doc4.xml…